Researchers reported promising results from five studies, including the first cancer vaccine trial to demonstrate clinical benefit in melanoma, which was reported by Jeffrey S. Weber, MD, PhD, during the first clinical trials plenary session at the Annual Meeting.
In the second clinical trials plenary session at the Annual Meeting, positive results were reported from four more studies. Timothy A. Yap, MD, PhD, reported on a study that provides the first clinical proof-of-concept for effectively drugging the Hippo-YAP pathway.
During her presidential address Sunday evening, AACR President Lisa M. Coussens, PhD, FAACR, compared advances in cancer research to her own career journey and shared her hopes for the future of cancer research.
The last five forum sessions at the Annual Meeting will examine topics including biostatistics in clinical research, engaging diverse communities in clinical trials, and overcoming cancer workforce challenges.